A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Public ClinicalTrials.gov record NCT02952534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer Associated With Homologous Recombination Deficiency
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to treatment with rucaparib.
Study identification
- NCT ID
- NCT02952534
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 277 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2017 (Actual)
- Primary completion
- Jul 18, 2021 (Actual)
- Completion
- Jul 27, 2021 (Actual)
- Last update posted
- Jun 9, 2023
2017 – 2021
United States locations
- U.S. sites
- 58
- U.S. states
- 28
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Mayo Clinc | Phoenix | Arizona | 85259 | — |
| Arizona Oncology Associates | Tucson | Arizona | 85704 | — |
| Alliance Research Centers | Laguna Hills | California | 92653 | — |
| VA Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | — |
| University of Southern California | Los Angeles | California | 90211 | — |
| Stanford University | Palo Alto | California | 94305 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| San Francisco VA Health Care System | San Francisco | California | 94143 | — |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94158 | — |
| Redwood Regional Medical Group | Santa Rosa | California | 95406 | — |
| Kaiser Permanente Medical Center (Vallejo) | Vallejo | California | 94589 | — |
| Rocky Mountain Cancer Centers | Aurora | Colorado | 80012 | — |
| Yale School of Medicine | New Haven | Connecticut | 06510 | — |
| 4701 Ogletown Stanton Rd. | Newark | Delaware | 19713 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Boca Raton Community Hospital, Inc. | Boca Raton | Florida | 33486 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33980 | — |
| University of Florida Health Cancer Center | Orlando | Florida | 32806 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Atlanta Urological Group | Atlanta | Georgia | 30312 | — |
| University of Chicago Comprehensive Cancer Center | Chicago | Illinois | 60637 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Walter Reed Hospital | Bethesda | Maryland | 48202 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| VA Ann Arbor Healthcare System | Ann Arbor | Michigan | 48105 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Fairview Hospital | Edina | Minnesota | 55435 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| Minnesota Veterans Research Institute | Minneapolis | Minnesota | 55417 | — |
| HCA Midwest Division - Kansas City | Kansas City | Missouri | 64132 | — |
| Alegent Health Bergan Mercy Hospital , GU Research Network | Omaha | Nebraska | 68130 | — |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89119 | — |
| Premier Urology Associates dba/AdvanceMed Research | Lawrenceville | New Jersey | 08648 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| Roswell Park | Buffalo | New York | 14263 | — |
| NYU Perlmutter Cancer Center | New York | New York | 10016 | — |
| Memorial Sloan Kettering CC | New York | New York | 10065 | — |
| Weill Cornell Medical College/NewYork-Presbyterian Hospital | New York | New York | 10065 | — |
| Premier Medical Group of the Hudson Valley PC | Poughkeepsie | New York | 12301 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Carolina Urology Partners | Concord | North Carolina | 28025 | — |
| The Urology Group | Cincinnati | Ohio | 45212 | — |
| Kettering Cancer Center | Kettering | Ohio | 45429 | — |
| Clinical Research Solutions | Middleburg Heights | Ohio | 44130 | — |
| VA Portland Health Care System | Portland | Oregon | 97219 | — |
| Consultants in Medical Oncology Hematology | Horsham | Pennsylvania | 19044 | — |
| SCRI - Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| Texas Oncology Medical City Dallas | Dallas | Texas | 75320 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| UT Health Science Center | Houston | Texas | 77030 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| VA Puget Sound | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02952534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02952534 live on ClinicalTrials.gov.